info

Friday 24 November 2017

Maternal Smoking and Perinatal Outcomes



Nicotine is one of the major components in tobacco smoke, and it can cross the placenta. It enters the fetal circulation and accumulates in the fetal compartments from as early as seven weeks of gestation, even with passive smoking. Elevated fetal carbon monoxide levels may result in hypoxia due to reduced availability of hemoglobin for oxygen transport. Exposure to hazardous substances in cigarette smoke could lead to adverse pregnancy and birth outcomes. In particular, maternal nicotine exposure is associated with many adverse fetal, placental, and postnatal health outcomes, including both shortterm and long-term complications. Despite increased awareness of the harmful effects of smoking during pregnancy, approximately 20% of women continue to smoke throughout pregnancy in the world. Reducing smoking in pregnancy is a global public-health priority. We recommend clinical and public-health strategies aimed at the primary and secondary prevention of tobacco exposure for fetuses and children.

The World Health Organization (WHO) estimates that the prevalence of smoking is approximately 22% of women in developed countries and 9% of women in underdeveloped countries. The 2011 Pregnancy Risk Assessment Monitoring System (PRAMS) polled women from 24 states in the US. The self-reported data showed that about 23% of reproductive-aged women smoked during the three months before pregnancy, and about 10% of women smoked during the last three months of pregnancy. About 55% of women who smoked before pregnancy reported they had quit smoking by the last three months of pregnancy. The highest prevalence of those smoking during the last three months of pregnancy (15-16%) was in the age groups of 24 years and younger (Figure 1). A strong correlation has been seen between maternal smoking during pregnancy and young age, unmarried status, and being from a low socioeconomic status.

The Centers for Disease Control and Prevention’s (CDC) PRAMS showed the trends of smoking three months before pregnancy, during, and after pregnancy data from 40 states in the US from 2000 to 2010. During this decade, the prevalence of smoking in the three months before pregnancy remained unchanged at about one in four women. However, the prevalence of smoking declined in the last three months of pregnancy from 13.2% to 11.6% and after delivery from 17.8% to 16.6%. The data showed that 40% of women who quit smoking during pregnancy relapsed within six months after delivery.

Other parts of the world had a greater decrease in smoking for women. Dias-Dame et al., conducted population-based survey in Brazil, data of 7,572 women showed that the prevalence of smoking before pregnancy decreased from 28% in 2007 to 22% in 2013, and the prevalence of smoking during pregnancy decreased from 22% in 2007 to 18% in 2013. In Australia, the prevalence of smoking in pregnancy in New South Wales declined from 22.1% in 1994 to 13.5% in 2007. The largest decrease in smoking in pregnancy rates was among the highest socioeconomic group, and smaller declines were observed among teenage and remote rural mothers.


No comments:

Post a Comment

An Evaluation of the Role of fMRI in Patients with Lower Urinary Tract Dysfunction

                                                 https://www.austinpublishinggroup.com/urology/ Patientswith Lower Urinary Tr...